| Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission JD Watkins, AM Sholukh, MM Mukhtar, NB Siddappa, SK Lakhashe, ... Aids 27 (9), F13-F20, 2013 | 129 | 2013 |
| An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV JD Watkins, NB Siddappa, SK Lakhashe, M Humbert, A Sholukh, ... PloS one 6 (3), e18207, 2011 | 101 | 2011 |
| Evaluation of cell-based and surrogate SARS-CoV-2 neutralization assays AM Sholukh, A Fiore-Gartland, ES Ford, MD Miner, YJ Hou, LV Tse, ... Journal of Clinical Microbiology 59 (10), 10.1128/jcm. 00527-21, 2021 | 79 | 2021 |
| Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge AM Sholukh, JD Watkins, HK Vyas, S Gupta, SK Lakhashe, S Thorat, ... Vaccine 33 (17), 2086-2095, 2015 | 78 | 2015 |
| Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit NK Hurlburt, LJ Homad, I Sinha, MF Jennewein, AJ MacCamy, YH Wan, ... Communications biology 5 (1), 342, 2022 | 48 | 2022 |
| High community SARS-CoV-2 antibody seroprevalence in a ski resort community, Blaine County, Idaho, US. preliminary results CC McLaughlin, MK Doll, KT Morrison, WL McLaughlin, T O’Connor, ... Medrxiv, 2020 | 40 | 2020 |
| Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials AM Sholukh, A Fiore-Gartland, ES Ford, YJ Hou, V Tse, H Kaiser, A Park, ... medRxiv, 2020.12. 07.20245431, 2020 | 27 | 2020 |
| Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose AM Sholukh, SN Byrareddy, V Shanmuganathan, G Hemashettar, ... Retrovirology 11, 1-15, 2014 | 17 | 2014 |
| Isolation of monoclonal antibodies with predetermined conformational epitope specificity AM Sholukh, MM Mukhtar, M Humbert, SS Essono, JD Watkins, HK Vyas, ... PloS one 7 (6), e38943, 2012 | 16 | 2012 |
| B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin ES Ford, AM Sholukh, RM Boytz, SS Carmack, A Klock, K Phasouk, ... The Journal of clinical investigation 131 (9), 2021 | 15 | 2021 |
| Group CP. 2013 JD Watkins, AM Sholukh, MM Mukhtar, NB Siddappa, SK Lakhashe, ... Anti-HIV IgA isotypes: differential virion capture and inhibition of …, 0 | 7 | |
| Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit. Commun Biol 5: 342 NK Hurlburt, LJ Homad, I Sinha, MF Jennewein, AJ MacCamy, YH Wan, ... | 6 | 2022 |
| Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials. medRxiv 2020 AM Sholukh, A Fiore-Gartland, ES Ford, Y Hou, LV Tse, H Kaiser, A Park, ... Google Scholar, 0 | 6 | |
| Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration S Fiedler, SRA Devenish, AS Morgunov, A Ilsley, F Ricci, M Emmenegger, ... Scientific Reports 12 (1), 19791, 2022 | 5 | 2022 |
| Maternal Epstein-Barr virus-specific antibodies and risk of infection in Ugandan infants R Minab, W Bu, H Nguyen, A Wall, AM Sholukh, ML Huang, M Ortego, ... The Journal of Infectious Diseases 223 (11), 1897-1904, 2021 | 4 | 2021 |
| CD8+ T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination ES Ford, K Mayer-Blackwell, L Jing, AM Sholukh, RS Germain, ... Research Square, 2022 | 3 | 2022 |
| Serum concentration of antigen-specific IgG can substantially bias interpretation of antibody-dependent phagocytosis assay readout RS Germain, EL Bossard, L Corey, AM Sholukh Iscience 26 (9), 2023 | 2 | 2023 |
| Epstein-Barr Virus glycoprotein antibody titers and risk of nasopharyngeal carcinoma AE Coghill, A McGuire, S Sinha, L Homad, I Sinha, A Sholukh, WP Koh, ... Open Forum Infectious Diseases 9 (12), ofac635, 2022 | 2 | 2022 |
| Soluble human CXCR2: Structure, properties, bioactivity K Katlinski, S Akalovich, Y Katlinskaya, A Sholukh, T Doroshenko, ... Cytokine 1 (48), 2, 2009 | 2 | 2009 |
| Isolation and identification of tyrosine kinase from the cytosolic fraction of bovine retinal rod outer segments AM Sholukh, ID Artamonov, LA Baranova, VM Lipkin, ID Volotovskiĭ Molekuliarnaia Biologiia 35 (3), 510-514, 2001 | 2 | 2001 |
